-
Nanomedicine for Drug Delivery, Controlled Release, and Targeted Therapy
Online Presentations | 07 Dec 2023 | Contributor(s):: Neda Habibi, The Micro Nano Technology - Education Center
Drug targeting to specific organs and tissues has become one of the critical endeavors of the century since the use of free drugs in conventional dosage forms generally involves difficulties in achieving the target site at the appropriate dose after or during a proper time period....
-
Cell Factory for Small Molecule Inducible Delivery of Low Dose IL-2
Online Presentations | 31 Aug 2023 | Contributor(s):: Celsa Pachlhofer, Yafet Arefeayne, Rice University
Autoimmune and inflammatory diseases are characterized by insufficient regulatory T cells (Treg), which play a central role in maintaining peripheral tolerance, preventing autoimmunity, and limiting chronic inflammation. Treg cells depend on IL-2 for survival and maintenance of their...
-
NanoMedicine
Online Presentations | 07 Oct 2022 | Contributor(s):: Jared Ashcroft, NACK Network
-
Nanotechnology: The Future of Medicine?
Online Presentations | 28 Jul 2022 | Contributor(s):: Jared Ashcroft, The Micro Nano Technology - Education Center
-
Nanomedicine for Drug Delivery, Controlled Release and Targeted Therapy
Online Presentations | 17 Jun 2022 | Contributor(s):: Neda Habibi, The Micro Nano Technology - Education Center
-
What are MEMS and Why Do We Care?
Online Presentations | 02 Aug 2021 | Contributor(s):: Matthias Pleil, The Micro Nano Technology - Education Center
This presentation will cover several devices and systems as well as an overview of current trends of the market.
-
Golden Opportunities: Gold Nanoparticles for Biomedical Applications
Online Presentations | 14 Jan 2020 | Contributor(s):: Catherine J. Murphy
In this talk I will discuss how these nanoparticles are prepared, how their surface chemistry can be tuned, how apparent cytotoxicity can be traced back to reagents in the synthesis rather than the particles per se, how protein orientation can be controlled on their surfaces, how cells respond...
-
[Illinois] Nanotechnology meets Biology in the Cancer Cell: Applications in Medicine, Drug Delivery, and Determining Drug Efficacy
Online Presentations | 04 Feb 2016 | Contributor(s):: Mostafa El-Sayed
-
[Illinois] Dimeric Trigger Responsive Drug Conjugate for High Loading Nanoencapsulates
Online Presentations | 26 Jan 2016 | Contributor(s):: kaimin Cai
Polymeric micelle is one of the most widely used drug delivery nanomedicine platforms; however, micelle drug delivery systems usually have very low drug loading and poorly defined composition, which greatly limited its further clinical translation. In the course of developing trigger responsive...
-
[Illinois] A Microfluidic Approach for Cocrystallization of Drugs and Analysis via X-ray Diffraction
Online Presentations | 16 Dec 2013 | Contributor(s):: Elizabeth Horstman
The process of pharmaceutical drug development is cost- and time-intensive. Candidate drugs (CDs) are screened with many counter ions (salt or cocrystal formers) to find solid forms of the drug with appropriate physicochemical (e.g., solubility, dissolution rate) properties. Cocrystals are...
-
[Illinois] Microcapsules for Luminescent Tracking and Controlled Drug Delivery
Online Presentations | 16 Dec 2013 | Contributor(s):: Yulia Maximenko
Polyelectrolyte microcapsules are formed on porous calcium carbonate templates that are impregnated and coated with 2.9 nanometer luminescent silicon nanoparticles. The complexes are characterized in suspension as well as in thin films using fluorescence microscopy, optical microscopy, and x-ray...
-
[Illinois] B3SI 2012: Circumventing Barriers to Nanoparticle Delivery In Vivo
Online Presentations | 02 Aug 2012 | Contributor(s):: Susan E. Clare
…
-
The Importance of Zeta Potential for Drug/Gene Delivery in Nanomedicine
Online Presentations | 11 Apr 2012 | Contributor(s):: James Leary
Keynote Address
-
KIST/PU Theragnosis – A New Paradigm of Personalized Medicine
Online Presentations | 06 Dec 2011 | Contributor(s):: Ick Chan Kwon
Companion Diagnosis, based on pharmacogenomics, has been recognized as one of most important key representatives of personalized medicine. However, Companion Diagnosis does not provide any clues in developing new ways of therapeutics but it only provides a best choice of drugs based on given...
-
Illinois BioNanotechnology Seminar Series Fall 2011: Precisely Size Controlled Drug-silica Nanoconjugate for Cancer Therapy
Online Presentations | 05 Dec 2011 | Contributor(s):: Li Tang
Drug delivery nanomedicine, exemplified by micelles and nanoparticles roughly in the size range of 1-200 nm, have attracted much interest in the past 2-3 decades as alternative modalities for cancer treatment. The size of these drug delivery vehicles has been strongly correlated with their in...
-
BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention
Online Presentations | 02 Dec 2011 | Contributor(s):: Deborah W Knapp
Guest lecturer: Deborah Knapp.
-
BME 695L Lecture 15: GMP and Issues of Quality Control Manufacture of Nanodelivery Systems
Online Presentations | 02 Dec 2011 | Contributor(s):: James Leary
See references below for related reading.15.1 Overview15.1.1 What does cGMP mean?15.1.2 Why GMP? Controlling processes means more predictable...
-
BME 695L Lecture 12: Assessing Drug Efficacy and Nanotoxicity at the Single Cell Level
Online Presentations | 22 Nov 2011 | Contributor(s):: James Leary
See references below for related reading.12.1 Introduction to measures of efficacy for nanomedicine12.1.1 for evaluation purposes, does structure/size reveal function?12.1.2 nanomedical treatment at the single cell...
-
BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use
Online Presentations | 22 Nov 2011 | Contributor(s):: James Leary
See references below for related reading.13.1 Bringing in-vivo considerations into NMS design13.1.1 the in-vitro to ex-vivo to in-vivo paradigm 13.1.1.1 In-vitro - importance of choosing...
-
BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems
Online Presentations | 22 Nov 2011 | Contributor(s):: James Leary
See references below for related reading.14.1 Introduction to integrated designs14.1.1 “Total design” but there is some order in the design process14.1.2 A brief outline of the total design...